Ten years experience with oral immunosuppressive treatment in adult patients with atopic dermatitis in two academic centres

Journal of the European Academy of Dermatology and Venereology

Volumn 29, Issue 10, 2015, Pages 1905-1912

  Garritsen, F M ^a   Roekevisch, E ^a   Van Der Schaft, J ^b   Deinum, J ^b   Spuls, P I ^a   De Bruin Weller, M S ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BETAMETHASONE; CREATININE; CYCLOSPORIN A; EFALIZUMAB; ETRETIN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; MYCOPHENOLATE MOFETIL; MYCOPHENOLIC ACID; PREDNISONE; PSORALEN; TACROLIMUS; CYCLOSPORIN; GLUCOCORTICOID;

ADULT; ANEMIA; ARTHROPATHY; ARTICLE; ATOPIC DERMATITIS; CREATININE BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; DRUG USE; DRUG WITHDRAWAL; DYSPNEA; EDEMA; ENTERIC COATED TABLET; FATIGUE; FEMALE; FLU LIKE SYNDROME; FLUSHING; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GINGIVA HYPERPLASIA; HAIR LOSS; HERPES SIMPLEX; HUMAN; HYPERTENSION; HYPERTRANSAMINASEMIA; HYPERTRICHOSIS; IMMUNOSUPPRESSIVE TREATMENT; LIVER DYSFUNCTION; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MONOTHERAPY; MOOD CHANGE; MYALGIA; NAUSEA; NEUROLOGIC DISEASE; PANCYTOPENIA; PETECHIA; PHOTOTHERAPY; PRESCRIPTION; PRIORITY JOURNAL; PUVA; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT VIRUS INFECTION; SIDE EFFECT; SYSTEMIC THERAPY; TREATMENT DURATION; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; UNIVERSITY HOSPITAL; UNSPECIFIED SIDE EFFECT; ANALOGS AND DERIVATIVES; CLINICAL TRIAL; DERMATITIS, ATOPIC; MIDDLE AGED; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; YOUNG ADULT;

ACADEMIC MEDICAL CENTERS; ADMINISTRATION, ORAL; ADULT; AZATHIOPRINE; CYCLOSPORINE; DERMATITIS, ATOPIC; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; METHOTREXATE; MIDDLE AGED; MYCOPHENOLIC ACID; TACROLIMUS; YOUNG ADULT;

EID: 84942293735     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.13064     Document Type: Article

References (22)

1. Asher MI, Montefort S, Björkstén B, et al., Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006; 368: 733-743.
2. Bieber T,. Atopic dermatitis. Ann Dermatol 2010; 22: 125-137.
3. Ring J, Alomar A, Bieber T, et al., Guidelines for treatment of atopic eczema (atopic dermatitis) part I. J Eur Acad Dermatol Venereol 2012; 26: 1045-1060.
4. Gambichler T,. Management of atopic dermatitis using photo(chemo)therapy. Arch Dermatol Res 2009; 301: 197-203.
5. Meduri NB, Vandergriff T, Rasmussen H, Jacobe H,. Phototherapy in the management of atopic dermatitis: a systematic review. Photodermatol Photoimmunol Photomed 2007; 23: 106-112.
6. Garritsen FM, Brouwer MW, Limpens J, Spuls PI,. Photo(chemo)therapy in the management of atopic dermatitis: an updated systematic review with implications for practice and research. Br J Dermatol 2014; 170: 501-513.
7. Sidbury R, Davis DM, Cohen DE, et al., Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. J Am Acad Dermatol 2014; 71: 327-349.
8. Schram ME, Roekevisch E, Leeflang MM, Bos JS, Schmitt J, Spuls PI,. A randomized trial of methotrexate versus azathioprine for severe atopic eczema. J Allergy Clin Immunol 2011; 128: 353-359.
9. Haeck IM, Knol MJ, ten Berge O, van Velsen SG, de Bruin-Weller MS, Bruijnzeel-Koomen CA,. Enteric-coated mycophenolate sodium versus cyclosporin A as long-term treatment in adult patients with severe atopic dermatitis: a randomized controlled trial. J Am Acad Dermatol 2011; 64: 1074-1084.
10. Schmitt J, Schäkel K, Fölster-Holst R, et al., Prednisolone vs. ciclosporin for severe adult eczema. An investigator-initiated double-blind placebo-controlled multicenter trial. Br J Dermatol 2010; 162: 661-668.
11. Roekevisch E, Spuls PI, Kuester D, Limpens J, Schmitt J,. Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: a systematic review. J Allergy Clin Immunol 2014; 133: 429-438.
12. Hanifin JM, Cooper KD, Ho VC, et al., Guidelines of care for atopic dermatitis, developed in accordance with the American Academy of Dermatology (AAD)/American Academy of Dermatology Association "Administrative Regulations for Evidence- Based Clinical Practice Guidelines". J Am Acad Dermatol 2004; 50: 391-404.
13. Hoare C, Li Wan Po A, Williams H,. Systematic review of treatments for atopic eczema. Health Technol Assess 2000; 4: 1-191.
14. Schmitt J, Schäkel K, Schmitt N, Meurer M,. Systemic treatment of severe atopic eczema: a systemic review. Acta Derm Venereol 2007; 87: 100-111.
15. Saeki H, Furue M, Furukawa F, et al., Guidelines for management of atopic dermatitis. J Dermatol 2009; 36: 563-577.
16. Williams HC,. Clinical practice. Atopic dermatitis. N Engl J Med 2005; 352: 2314-2324.
17. Dutch Society of Dermatology and Venereology Quality Institute for Healthcare CBO. Dutch Guidelines for the Treatment of Atopic Dermatitis, Utrecht, the Netherlands, 2014.
18. Ring J, Alomar A, Bieber T, et al., Guidelines for treatment of atopic eczema (atopic dermatitis) Part II. J Eur Acad Dermatol Venereol 2012; 26: 1176-1193.
19. Brenninkmeijer EE, Schram ME, Leeflang MM, Bos JD, Spuls PI,. Diagnostic criteria for atopic dermatitis: a systematic review. Br J Dermatol 2008; 158: 754-765.
20. von Elm E, Altman DG, Egger M, et al., The strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 2008; 61: 344-349.
21. van den Reek JM, van Lümig PP, Driessen RJ, et al., Determinants of drug survival for etanercept in a long-term daily practice cohort of patients with psoriasis. Br J Dermatol 2014; 170: 415-424.
22. Proudfoot LE, Powell AM, Ayis S, et al., The European TREatment of severe Atopic eczema in children Taskforce (TREAT) survey. Br J Dermatol 2013; 169: 901-909.